Cancer

“Pick Up Your Poop” F Cancer’s New Campaign Encourages At-Home Colorectal Cancer Screening

Humorous PSA Highlights the Irony of Pet Owners' Willingness to Handle Dog Waste While Avoiding Their Own Screening COSTA MESA, Calif.,…

9 months ago

BillionToOne Celebrates Major Milestone: 1 Million UNITY Tests

UNITY is the only commercially available non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens…

9 months ago

Clearwater Joins CancerX to Help Drive Strong Cybersecurity and Data Privacy Practices in the Fight Against Cancer

New Initiative Part of Company's Mission to Move Organizations Across the Healthcare Ecosystem to a More Secure, Compliant, and Resilient State…

9 months ago

SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC

BOSTON, MA and ROLLE, Switzerland, March 18, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader…

9 months ago

TOGETHXR and Aflac Put More Ducks in a Row for Women’s Sports

Continued partnership launches Raise the Bar campaign for equal basketball tournament tune-ins from March 17-April 6 TOGETHXR.com published a digital map…

9 months ago

Canopy and Texas Oncology Announce Multi-Year Partnership to Improve Patient Outcomes

NEW YORK, March 18, 2025 /PRNewswire/ -- Canopy, the first Continuous Care Platform for oncology, today announced a multi-year partnership with…

9 months ago

Leading Academic and Manufacturing Organizations Join Ori Biotech’s Preferred Partner Network to Accelerate the Commercialization of Cell and Gene Therapies

Two IRO Platforms Ori Biotech’s IRO Platform The IRO Platform in Use A scientist uses the IRO Platform 8 IRO…

9 months ago

Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain

-- Company taps first EU distributors, Comercial Medico Quirurigca, SA and Durgalab, as the first globally to be granted rights…

9 months ago

Dogwood Therapeutics Announces Dosing of First Patient in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy-Induced Neuropathic Pain

Opioid-free and addiction-free pain treatment therapy could address $1.5B worldwide CINP marketATLANTA, March 18, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics,…

9 months ago

March 2025 Letter to Shareholders

VANCOUVER, Washington, March 18, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, As envisioned, 2025 is unfolding to be an exciting year…

9 months ago